Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Meir Jakobsohn Insider Profile
4 Followers
Meir Jakobsohn, Director at Knight Therapeutics, holds 10.42M shares in Knight Therapeutics (Ticker: KHTRF). Most recently, Meir Jakobsohn Sold $27,600 shares of Knight Therapeutics on Jun 06, 2018 for an estimated value of 221.58K.
Profitable Transactions
14 out of 14 Profitable Transactions
Average Return
+12.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Meir Jakobsohn's holdings
Insider Roles
Director
Roles that Meir Jakobsohn holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jun 21, 2016 - Jun 21, 2017
Return:+20.00%
The most profitable trade made by Meir Jakobsohn
Meir Jakobsohn's Trading History
List of latest transactions for each holding click on a transaction to see Meir Jakobsohn's performance on stock
You May Also Like
Meir Jakobsohn insider profile FAQ
What is the percentage of profitable transactions made by Meir Jakobsohn?
The percentage of profitable transactions made by Meir Jakobsohn is 100%.
What is the average return per transaction made by Meir Jakobsohn?
The average return per transaction made by Meir Jakobsohn is 12.40%.
What stocks does Meir Jakobsohn hold?
Meir Jakobsohn holds: KHTRF stocks.
What was Meir Jakobsohn’s latest transaction?
Meir Jakobsohn latest transaction was an Informative Sell of $221.58K.
What was Meir Jakobsohn's most profitable transaction?
Meir Jakobsohn’s most profitable transaction was an Informative Buy of KHTRF stock on June 21, 2016. The return on the trade was 20.00%.
What is Meir Jakobsohn's role in Knight Therapeutics?
Meir Jakobsohn's role in Knight Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.